Stock Events

Lotus Pharmaceutical 

TWD272
0
+TWD0+0% Friday 05:30

Statistics

Day High
275
Day Low
271
52W High
349.5
52W Low
205
Volume
2,273,657
Avg. Volume
6,596,377
Mkt Cap
71.26B
P/E Ratio
18.38
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Aug 23
TWD3.46
Aug 22
TWD1.93
Aug 21
TWD0.35
Oct 11
TWD0.3
Sep 10
TWD0.1

Earnings

7MarExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
1.14
3.4
5.67
7.93
Expected EPS
1.2
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1795.TW. It's not an investment recommendation.

About

Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease. The company also sells and markets a portfolio of over-the-counter medicines. In addition, it engages in wholesale of cosmetics; retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. The company has an agreement with NeuroRx Inc. to develop, manufacture, and commercialize NRX-101. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited.
Show more...
CEO
Mr. Petar Antonov Vazharov
Country
TW
ISIN
TW0001795003

Listings